Resources
About Us
Home Report
Store
Veterinary Vaccines Market
Veterinary Vaccines Market by Type (Live, Inactive, Recombinant) Animal (Livestock [Ruminant, Poultry, Pig], Companion [Dog, Cat]) Administration Route (Oral, Parenteral, Nasal) Distribution Channel (Hospital & Clinic, Pharmacy) - Global Forecast to 2030
Report ID:MRHC - 104935 Pages: 250 Jul-2024 Formats*: PDF Category: Healthcare Delivery: 24 to 72 HoursThe Veterinary Vaccines Market is expected to record a CAGR of 6.1% from 2024 to 2030, reaching $11.13 billion by 2030. Veterinary vaccines are integral to the veterinary healthcare industry as they help prevent diseases and their spread. They also reduce the risk of transmission of infections from household pets to their owners. Several types of vaccines, such as live attenuated, inactive, recombinant, and other vaccines, are used to immunize livestock and companion animals. The most preferred administration route for animal vaccines is parenteral, as animals are reluctant to take medications, including vaccines.
The growth of this market is driven by the increasing livestock population, growing pet adoption, increasing prevalence of diseases in animals, and growing demand for animal-derived food products. Additionally, increasing awareness regarding animal health and growing expenditure on animal health and pet insurance are expected to create growth opportunities for the stakeholders in this market. However, the high cost of manufacturing and vaccine storage restrain the growth of this market. Low awareness regarding animal health in developing countries is a major challenge to market growth.
Rising Demand for Animal-derived Food Products to Drive the Market
The demand for animal-derived food products, namely meat, milk, and eggs, has increased. The consumption of animal-derived foods is increasing due to decreasing agricultural productivity on account of shrinking resources and reduced availability of cultivable land. Foods derived from animals are a major source of protein, and a protein-rich diet is essential to leading a healthy life.
Consumption of animal proteins is stable (around 44 to 55 g/capita/day) in developed countries, while consumption is increasing in developing countries. For instance, in 2020, the U.S. accounted for approximately 21% of global beef consumption. In 2020, beef and veal consumption in Asia reached 19,656.46 thousand tons, which is expected to increase to 21,467.08 thousand tons by 2026 (Source: OECD FAO). Farmers are expected to increase livestock production to meet the increasing demand for animal-derived foods. Increased livestock production will encourage the adoption of vaccines for animals. The use of vaccines can help ensure the safety and quality of animal-derived food products by preventing the spread of diseases. This is one of the major factors driving the market growth.
Click here to: Get Free Sample Pages of this Report
Growing Expenditure on Animal Health and Pet Insurance Provides Opportunities for the Players Operating in the Market
Global veterinary healthcare expenditure has increased over the years. People are willing to spend substantial money on caring for their pets. According to the American Pet Products Association, people in the U.S. spent approximately USD 90.5 billion on their pets in 2018, which increased to USD 136.8 billion in 2022. Veterinary care (including vaccines) and product sales accounted for USD 35.9 billion in 2022, an increase of 4.7% compared to 2021.
Moreover, according to the North American Pet Health Insurance Association (NAPHIA), the pet health insurance sector in the U.S. and Canada registered a combined gross written premium of USD 3.51 billion in 2020, up 23.5% from USD 2.84 billion in 2021. The total number of pets insured reached 5.36 million in 2022, an increase of 21.7% from 4.4 million in 2021.
Furthermore, there was a rise in pet adoption in Australia. According to Animal Medicines Australia, pet ownership in Australia increased to 68.7% of households having pets in 2022 from 61% in 2019. This increase led to a rise in pet-related expenditures & adoption of pet insurance in Australia. For instance, total expenditure on pet health increased to USD 33.2 billion in 2022 from USD 13 billion in 2019 annually. In 2022, veterinary services, including routine vaccinations, increased to USD 4.7 billion in 2022 compared to USD 2.6 billion in 2019.
The growing expenditure on pet health and veterinary services and growing adoption of pet insurance is expected to increase the utilization of routine vaccinations, providing an opportunity for the players operating in the veterinary vaccines market.
Key Findings of the Veterinary Vaccines Market Study:
The Live Attenuated Vaccines Segment to Dominate the Veterinary Vaccines Market in 2024
Live attenuated vaccines use weakened or dormant organisms, which help create a blueprint to fight the infections against the disease by initiating cell-mediated immune responses. Live attenuated vaccines are very effective in dangerous and deadly diseases in animals. Live attenuated vaccines imitate the natural infections they can help prevent, creating a strong and long-lasting immune response. Thus, a higher preference for live attenuated vaccines supports its largest share.
The Livestock Segment to Account for the Largest Market Share in 2024
The factors contributing to the segment’s large share are the large population of poultry and farm animals in developed and developing countries, high awareness regarding animal health amongst farmers in developed countries, and the growing demand for animal-derived food products globally. There has been a growing demand for animal-derived food products globally. To ensure good quality, disease food products, vaccinations play a crucial role in keeping farm animals healthy and disease-free preventing loss to farmers. The demand for animal-derived foods, such as meat, milk products, and eggs, has increased recently. According to the Food and Agriculture Organization of the United Nations (FAO), feeding the world population (7.9 billion) would require raising overall agri-food production by 50–70%, and global poultry meat consumption is expected to increase from 3,818.60 thousand tonnes in 2020 to 5,134.81 thousand tonnes in 2030.
Parenteral Segment to Account for the Largest Market Share in 2024
The segment's large share is attributed to the animals’ especially pets’ reluctance towards oral vaccines and easy and high vaccine absorption through the intramuscular route. Muscle tissues have a generous blood supply; therefore, the vaccines administered are readily absorbed into the bloodstream.
Hospitals & Clinics Segment to Account for the Largest Market Share in 2024
The segment's large share is attributed to animal owners' high preference for hospitals & clinics, easy accessibility, and the growing burden of diseases in animals. To control and prevent the growing incidence of zoonotic diseases and prevent the deterioration of animal health by disease infections, vaccines play a crucial role. Veterinarians in hospitals and clinics are highly skilled, and the vaccines must be administered only by licensed professionals. Veterinary hospitals and clinics provide animal vaccination services, as vaccines should be administered in certain periods.
Asia-Pacific to Be the Fastest-Growing Regional Market
In 2024, North America is expected to dominate the veterinary vaccines market, while Asia-Pacific is expected to record the highest CAGR during the forecast period. The high growth of the Asia-Pacific veterinary vaccines market is attributed to the growing population of pet animals, growing demand and consumption of animal-derived food proteins, presence of large exporters of animal products, government initiatives to improve agricultural and animal husbandry outcomes, and the rising incidence of various zoonotic diseases in the region.
Key Players
The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presence, and key strategic developments adopted by leading market players in this market in the last three to four years. The key players profiled in the veterinary vaccines market are Zoetis Inc. (U.S.), Virbac (France), Ceva Santé Animale (France), Boehringer Ingelheim International GmbH (Germany), Phibro Animal Health Corporation (U.S.), Merck & Co., Inc (U.S.), Elanco Animal Health Inc. (U.S.), Vetoquinol (France), Neogen Corporation (U.S.), and Indian Immunologicals Ltd. (India).
Scope of the Report:
Veterinary Vaccines Market Assessment, by Type
- Live Attenuated Vaccines
- Inactive Vaccines
- Recombinant Vaccines
- Other Vaccines
(Note: Other vaccines include Gene deleted, virus vector, subunit, DNA Plasmid, and Toxoid)
Veterinary Vaccines Market Assessment, by Animal Type
- Livestock
- Ruminants
- Poultry
- Porcine
- Other Livestock
(Note: Other livestock include zoo animals, horses, and camels)
- Companion Animals
- Canine
- Feline
- Other Companion Animals
(Note: Other Companion animals segment covers rabbits, guinea pigs, fish, and other small animals).
Veterinary Vaccines Market Assessment, by Administration Route
- Parenteral
- Oral
- Intranasal
Veterinary Vaccines Market Assessment, by Distribution Channel
- Veterinary Hospitals & Clinics
- Pharmacies
- Mobile Veterinary Units
Veterinary Vaccines Market Assessment, by Geography
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe (RoE)
- Asia-Pacific (APAC)
- Japan
- China
- India
- Rest of APAC (RoAPAC)
- Latin America
- Brazil
- Mexico
- Rest of Latin America (RoLATAM)
- Middle East & Africa
Key Questions Answered in the Report:
The veterinary vaccines market report covers market sizes & forecasts for live attenuated, inactive, recombinant, and other vaccines used for animal immunization. The veterinary vaccines market study includes the value analysis of various segments and subsegments of the veterinary vaccines market at the regional and country levels.
The veterinary vaccines market is projected to reach $11.13 billion by 2030, at a CAGR of 6.1% from 2024 to 2030.
The live attenuated segment is estimated to account for the largest share of the veterinary vaccines market in 2024. Moreover, this segment is expected to record the highest CAGR during the forecast period.
Based on animal type, the livestock segment is projected to gain more traction in the veterinary vaccines market.
The high growth of the veterinary vaccines market is mainly attributed to the increasing livestock population, growing pet adoption, increasing prevalence of diseases in animals, and growing demand for animal-derived food products. Moreover, increasing awareness regarding animal health and growing expenditure on animal health and pet insurance offer market growth opportunities.
The key players operating in the veterinary vaccines market are Zoetis Inc. (U.S.), Virbac (France), Ceva Santé Animale (France), Boehringer Ingelheim International GmbH (Germany), Phibro Animal Health Corporation (U.S.), Merck & Co., Inc (U.S.), Elanco Animal Health Inc. (U.S.), Vetoquinol (France), Neogen Corporation (U.S.), and Indian Immunologicals Ltd. (India).
The emerging Asian-Pacific countries are expected to offer significant growth opportunities for the vendors in this market due to the growing population of pet animals, growing demand and consummation of animal-derived food proteins, presence of large exporters of animal products, government initiatives to improve agricultural and animal husbandry outcomes, and the rising incidence of various zoonotic diseases in the region.
1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.4. Assumptions for this Study
3. Executive Summary
4. Market Insights
4.1. Market Overview
4.2. Drivers
4.2.1. Increasing Livestock Population
4.2.2. Increasing Pet Population
4.2.3. Rising Prevalence of Zoonotic and Animal Diseases
4.2.4. Rising Demand for Animal-derived Food Products
4.3. Restraints
4.3.1. High Cost of Vaccine Manufacturing and Storage
4.4. Opportunity
4.4.1. Increasing Awareness Regarding Animal Health
4.4.2. Growing Expenditure on Animal Health and Pet Insurance
4.5. Challenges
4.5.1. Low Awareness Regarding Animal Health in Developing Countries
4.6. Trends
4.7. Pricing Analysis
4.8. Regulatory Analysis
4.9. Porters Five Force Analysis
4.9.1. Bargaining Power of Buyers
4.9.2. Bargaining Power of Suppliers
4.9.3. Threat of Substitute
4.9.4. Threat of New Entrant
4.9.5. Degree of Competition
5. Veterinary Vaccines Market—by Type
5.1. Introduction
5.2. Live Attenuated Vaccines
5.3. Inactive Vaccines
5.4. Recombinant Vaccines
5.5. Other Vaccines
6. Veterinary Vaccines Market Assessment —by Animal Type
6.1. Introduction
6.2. Livestock
6.2.1. Ruminants
6.2.2. Poultry
6.2.3. Porcine
6.2.4. Other Livestock
6.3. Companion Animals
6.3.1. Canine
6.3.2. Feline
6.3.3. Other Companion Animals
7. Veterinary Vaccines Market—by Administration Route
7.1. Introduction
7.2. Parenteral
7.3. Oral
7.4. Intranasal
8. Veterinary Vaccines Market—by Distribution Channel
8.1. Introduction
8.2. Veterinary Hospitals & Clinics
8.3. Pharmacies
8.4. Mobile Veterinary Units
9. Veterinary Vaccines Market—by Geography
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.4.4. Rest of Asia-Pacific
9.5. Latin America
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America
9.6. Middle East & Africa
10. Competition Analysis
10.1 Overview
10.2 Key Growth Strategies
10.3 Competitive Benchmarking
10.4 Competitive Dashboard
10.4.1. Industry Leaders
10.4.2. Market Differentiators
10.4.3. Vanguards
10.4.4. Emerging Companies
10.5. Market Share Analysis
11. Company Profiles (Company Overview, Financial Overview, Product Portfolio, and Strategic Developments)
11.1. Zoetis Inc.
11.2. Virbac
11.3. Ceva Santé Animale
11.4. Boehringer Ingelheim International
11.5. Phibro Animal Health Corporation
11.6. Merck & Co., Inc
11.7. Elanco Animal Health Inc.
11.8. Vetoquinol
11.9. Neogen Corporation
11.10. Indian Immunologicals Ltd.
(Note: SWOT Analysis of Top 5 Companies Will Be Provided)
12. Appendix
12.1. Available Customization
12.2. Related Reports
List of Tables
Table 1 Global Veterinary Vaccines Market Drivers: Impact Analysis (2022–2030)
Table 2 Global Veterinary Vaccines Market Restraints: Impact Analysis (2022–2030)
Table 3 Global Veterinary Vaccines Market, by Type, 2021–2030 (USD Million)
Table 4 Global Veterinary Live Attenuated Vaccines, by Country/Region, 2021–2030 (USD Million)
Table 5 Global Veterinary Inactive Vaccines Market, by Country/Region, 2021–2030 (USD Million)
Table 6 Global Veterinary Recombinant Vaccines Market, by Country/Region, 2021–2030 (USD Million)
Table 7 Global Other Veterinary Vaccines Market, by Country/Region, 2021–2030 (USD Million)
Table 8 Global Veterinary Vaccines Market, by Animal Type, 2021–2030 (USD Million)
Table 9 Global Livestock Animals Vaccines Market, by Type, 2021–2030 (USD Million)
Table 10 Global Veterinary Vaccines Market for Livestock, by Country/Region, 2021–2030 (USD Million)
Table 11 Global Ruminant Vaccines, by Country/Region, 2021–2030 (USD Million)
Table 12 Global Poultry Vaccines Market, by Country/Region, 2021–2030 (USD Million)
Table 13 Global Porcine Vaccines Market, by Country/Region, 2021–2030 (USD Million)
Table 14 Global Other Livestock Vaccines Market, by Country/Region, 2021–2030 (USD Million)
Table 15 Global Companion Animals Vaccines Market, by Type, 2021–2030 (USD Million)
Table 16 Global Companion Animals Vaccines Market, by Country/Region, 2021–2030 (USD Million)
Table 17 Global Canine Vaccines, by Country/Region, 2021–2030 (USD Million)
Table 18 Global Feline Vaccines Market, by Country/Region, 2021–2030 (USD Million)
Table 19 Global Other Companion Animal Vaccines Market, by Country/Region, 2021–2030 (USD Million)
Table 20 Global Veterinary Vaccines Market, by Administration Route, 2021–2030 (USD Million)
Table 21 Global Parenteral Veterinary Vaccines Market, by Country/Region, 2021–2030 (USD Million)
Table 22 Global Oral Veterinary Vaccines Market, by Country/Region, 2021–2030 (USD Million)
Table 23 Global Intranasal Veterinary Vaccines Market, by Country/Region, 2021–2030 (USD Million)
Table 24 Global Veterinary Vaccines Market, by Distribution Channel, 2021–2030 (USD Million)
Table 25 Global Veterinary Vaccines for Veterinary Hospitals & Clinics, by Country/Region, 2021–2030 (USD Million)
Table 26 Global Veterinary Vaccines Market for Pharmacies, by Country/Region, 2021–2030 (USD Million)
Table 27 Global Veterinary Vaccines Market for Mobile Veterinary Units, by Country/Region, 2021–2030 (USD Million)
Table 28 North America: Veterinary Vaccines Market, by Country, 2021–2030 (USD Million)
Table 29 North America: Veterinary Vaccines Market, by Type, 2021–2030 (USD Million)
Table 30 North America: Veterinary Vaccines Market, by Animal Type, 2021–2030 (USD Million)
Table 31 North America: Livestock Vaccines Market, by Type, 2021–2030 (USD Million)
Table 32 North America: Companion Animal Vaccines Market, by Type, 2021–2030 (USD Million)
Table 33 North America: Veterinary Vaccines Market, by Administration Route, 2021–2030 (USD Million)
Table 34 North America: Veterinary Vaccines Market, by Distribution Channel, 2021–2030 (USD Million)
Table 35 U.S.: Veterinary Vaccines Market, by Type, 2021–2030 (USD Million)
Table 36 U.S.: Veterinary Vaccines Market, by Animal Type, 2021–2030 (USD Million)
Table 37 U.S.: Livestock Vaccines Market, by Type, 2021–2030 (USD Million)
Table 38 U.S.: Companion Animal Vaccines Market, by Type, 2021–2030 (USD Million)
Table 39 U.S.: Veterinary Vaccines Market, by Administration Route, 2021–2030 (USD Million)
Table 40 U.S.: Veterinary Vaccines Market, by Distribution Channel, 2021–2030 (USD Million)
Table 41 Canada: Veterinary Vaccines Market, by Type, 2021–2030 (USD Million)
Table 42 Canada: Veterinary Vaccines Market, by Animal Type, 2021–2030 (USD Million)
Table 43 Canada: Livestock Vaccines Market, by Type, 2021–2030 (USD Million)
Table 44 Canada: Companion Animal Vaccines Market, by Type, 2021–2030 (USD Million)
Table 45 Canada: Veterinary Vaccines Market, by Administration Route, 2021–2030 (USD Million)
Table 46 Canada: Veterinary Vaccines Market, by Distribution Channel, 2021–2030 (USD Million)
Table 47 Europe: Veterinary Vaccines Market, by Country/Region, 2021–2030 (USD Million)
Table 48 Europe: Veterinary Vaccines Market, by Type, 2021–2030 (USD Million)
Table 49 Europe: Veterinary Vaccines Market, by Animal Type, 2021–2030 (USD Million)
Table 50 Europe: Livestock Vaccines Market, by Type, 2021–2030 (USD Million)
Table 51 Europe: Companion Animal Vaccines Market, by Type, 2021–2030 (USD Million)
Table 52 Europe: Veterinary Vaccines Market, by Administration Route, 2021–2030 (USD Million)
Table 53 Europe: Veterinary Vaccines Market, by Distribution Channel, 2021–2030 (USD Million)
Table 54 Germany: Veterinary Vaccines Market, by Type, 2021–2030 (USD Million)
Table 55 Germany: Veterinary Vaccines Market, by Animal Type, 2021–2030 (USD Million)
Table 56 Germany: Livestock Vaccines Market, by Type, 2021–2030 (USD Million)
Table 57 Germany: Companion Animal Vaccines Market, by Type, 2021–2030 (USD Million)
Table 58 Germany: Veterinary Vaccines Market, by Administration Route, 2021–2030 (USD Million)
Table 59 Germany: Veterinary Vaccines Market, by Distribution Channel, 2021–2030 (USD Million)
Table 60 France: Veterinary Vaccines Market, by Type, 2021–2030 (USD Million)
Table 61 France: Veterinary Vaccines Market, by Animal Type, 2021–2030 (USD Million)
Table 62 France: Livestock Vaccines Market, by Type, 2021–2030 (USD Million)
Table 63 France: Companion Animal Vaccines Market, by Type, 2021–2030 (USD Million)
Table 64 France: Veterinary Vaccines Market, by Administration Route, 2021–2030 (USD Million)
Table 65 France: Veterinary Vaccines Market, by Distribution Channel, 2021–2030 (USD Million)
Table 66 U.K.: Veterinary Vaccines Market, by Type, 2021–2030 (USD Million)
Table 67 U.K.: Veterinary Vaccines Market, by Animal Type, 2021–2030 (USD Million)
Table 68 U.K.: Livestock Vaccines Market, by Type, 2021–2030 (USD Million)
Table 69 U.K.: Companion Animal Vaccines Market, by Type, 2021–2030 (USD Million)
Table 70 U.K.: Veterinary Vaccines Market, by Administration Route, 2021–2030 (USD Million)
Table 71 U.K.: Veterinary Vaccines Market, by Distribution Channel, 2021–2030 (USD Million)
Table 72 Italy: Veterinary Vaccines Market, by Type, 2021–2030 (USD Million)
Table 73 Italy: Veterinary Vaccines Market, by Animal Type, 2021–2030 (USD Million)
Table 74 Italy: Livestock Vaccines Market, by Type, 2021–2030 (USD Million)
Table 75 Italy: Companion Animal Vaccines Market, by Type, 2021–2030 (USD Million)
Table 76 Italy: Veterinary Vaccines Market, by Administration Rute, 2021–2030 (USD Million)
Table 77 Italy: Veterinary Vaccines Market, by Distribution Channel, 2021–2030 (USD Million)
Table 78 Spain: Veterinary Vaccines Market, by Type, 2021–2030 (USD Million)
Table 79 Spain: Veterinary Vaccines Market, by Animal Type, 2021–2030 (USD Million)
Table 80 Spain: Livestock Vaccines Market, by Type, 2021–2030 (USD Million)
Table 81 Spain: Companion Animal Vaccines Market, by Type, 2021–2030 (USD Million)
Table 82 Spain: Veterinary Vaccines Market, by Administration Rute, 2021–2030 (USD Million)
Table 83 Spain: Veterinary Vaccines Market, by Distribution Channel, 2021–2030 (USD Million)
Table 84 RoE: Veterinary Vaccines Market, by Type, 2021–2030 (USD Million)
Table 85 RoE: Veterinary Vaccines Market, by Animal Type, 2021–2030 (USD Million)
Table 86 RoE: Livestock Vaccines Market, by Type, 2021–2030 (USD Million)
Table 87 RoE: Companion Animal Vaccines Market, by Type, 2021–2030 (USD Million)
Table 88 RoE: Veterinary Vaccines Market, by Administration Rute, 2021–2030 (USD Million)
Table 89 RoE: Veterinary Vaccines Market, by Distribution Channel, 2021–2030 (USD Million)
Table 90 Asia-Pacific: Veterinary Vaccines Market, by Type, 2021–2030 (USD Million)
Table 91 Asia-Pacific: Veterinary Vaccines Market, by Animal Type, 2021–2030 (USD Million)
Table 92 Asia-Pacific: Livestock Vaccines Market, by Type, 2021–2030 (USD Million)
Table 93 Asia-Pacific: Companion Animal Vaccines Market, by Type, 2021–2030 (USD Million)
Table 94 Asia-Pacific: Veterinary Vaccines Market, by Administration Rute, 2021–2030 (USD Million)
Table 95 Asia-Pacific: Veterinary Vaccines Market, by Distribution Channel, 2021–2030 (USD Million)
Table 96 Japan: Veterinary Vaccines Market, by Type, 2021–2030 (USD Million)
Table 97 Japan: Veterinary Vaccines Market, by Animal Type, 2021–2030 (USD Million)
Table 98 Japan: Livestock Vaccines Market, by Type, 2021–2030 (USD Million)
Table 99 Japan: Companion Animal Vaccines Market, by Type, 2021–2030 (USD Million)
Table 100 Japan: Veterinary Vaccines Market, by Administration Rute, 2021–2030 (USD Million)
Table 101 Japan: Veterinary Vaccines Market, by Distribution Channel, 2021–2030 (USD Million)
Table 102 China: Veterinary Vaccines Market, by Type, 2021–2030 (USD Million)
Table 103 China: Veterinary Vaccines Market, by Animal Type, 2021–2030 (USD Million)
Table 104 China: Livestock Vaccines Market, by Type, 2021–2030 (USD Million)
Table 105 China: Companion Animal Vaccines Market, by Type, 2021–2030 (USD Million)
Table 106 China: Veterinary Vaccines Market, by Administration Rute, 2021–2030 (USD Million)
Table 107 China: Veterinary Vaccines Market, by Distribution Channel, 2021–2030 (USD Million)
Table 108 India: Veterinary Vaccines Market, by Type, 2021–2030 (USD Million)
Table 109 India: Veterinary Vaccines Market, by Animal Type, 2021–2030 (USD Million)
Table 110 India: Livestock Vaccines Market, by Type, 2021–2030 (USD Million)
Table 111 India: Companion Animal Vaccines Market, by Type, 2021–2030 (USD Million)
Table 112 India: Veterinary Vaccines Market, by Administration Rute, 2021–2030 (USD Million)
Table 113 India: Veterinary Vaccines Market, by Distribution Channel, 2021–2030 (USD Million)
Table 114 RoAPAC: Veterinary Vaccines Market, by Type, 2021–2030 (USD Million)
Table 115 RoAPAC: Veterinary Vaccines Market, by Animal Type, 2021–2030 (USD Million)
Table 116 RoAPAC: Livestock Vaccines Market, by Type, 2021–2030 (USD Million)
Table 117 RoAPAC: Companion Animal Vaccines Market, by Type, 2021–2030 (USD Million)
Table 118 RoAPAC: Veterinary Vaccines Market, by Administration Rute, 2021–2030 (USD Million)
Table 119 RoAPAC: Veterinary Vaccines Market, by Distribution Channel, 2021–2030 (USD Million)
Table 120 Latin America: Veterinary Vaccines Market, by Country/Region, 2021–2030 (USD Million)
Table 121 Latin America: Veterinary Vaccines Market, by Type, 2021–2030 (USD Million)
Table 122 Latin America: Veterinary Vaccines Market, by Animal Type, 2021–2030 (USD Million)
Table 123 Latin America: Livestock Vaccines Market, by Type, 2021–2030 (USD Million)
Table 124 Latin America: Companion Animal Vaccines Market, by Type, 2021–2030 (USD Million)
Table 125 Latin America: Veterinary Vaccines Market, by Administration Rute, 2021–2030 (USD Million)
Table 126 Latin America: Veterinary Vaccines Market, by Distribution Channel, 2021–2030 (USD Million)
Table 127 Brazil: Veterinary Vaccines Market, by Type, 2021–2030 (USD Million)
Table 128 Brazil: Veterinary Vaccines Market, by Animal Type, 2021–2030 (USD Million)
Table 129 Brazil: Livestock Vaccines Market, by Type, 2021–2030 (USD Million)
Table 130 Brazil: Companion Animal Vaccines Market, by Type, 2021–2030 (USD Million)
Table 131 Brazil: Veterinary Vaccines Market, by Administration Rute, 2021–2030 (USD Million)
Table 132 Brazil: Veterinary Vaccines Market, by Distribution Channel, 2021–2030 (USD Million)
Table 133 Mexico: Veterinary Vaccines Market, by Type, 2021–2030 (USD Million)
Table 134 Mexico: Veterinary Vaccines Market, by Animal Type, 2021–2030 (USD Million)
Table 135 Mexico: Livestock Vaccines Market, by Type, 2021–2030 (USD Million)
Table 136 Mexico: Companion Animal Vaccines Market, by Type, 2021–2030 (USD Million)
Table 137 Mexico: Veterinary Vaccines Market, by Administration Rute, 2021–2030 (USD Million)
Table 138 Mexico: Veterinary Vaccines Market, by Distribution Channel, 2021–2030 (USD Million)
Table 139 Rest of Latin America: Veterinary Vaccines Market, by Type, 2021–2030 (USD Million)
Table 140 Rest of Latin America: Veterinary Vaccines Market, by Animal Type, 2021–2030 (USD Million)
Table 141 Rest of Latin America: Livestock Vaccines Market, by Type, 2021–2030 (USD Million)
Table 142 Rest of Latin America: Companion Animal Vaccines Market, by Type, 2021–2030 (USD Million)
Table 143 Rest of Latin America: Veterinary Vaccines Market, by Administration Rute, 2021–2030 (USD Million)
Table 144 Rest of Latin America: Veterinary Vaccines Market, by Distribution Channel, 2021–2030 (USD Million)
Table 145 Middle East & Africa: Veterinary Vaccines Market, by Type, 2021–2030 (USD Million)
Table 146 Middle East & Africa: Veterinary Vaccines Market, by Animal Type, 2021–2030 (USD Million)
Table 147 Middle East & Africa: Livestock Vaccines Market, by Type, 2021–2030 (USD Million)
Table 148 Middle East & Africa: Companion Animal Vaccines Market, by Type, 2021–2030 (USD Million)
Table 149 Middle East & Africa: Veterinary Vaccines Market, by Administration Rute, 2021–2030 (USD Million)
Table 150 Middle East & Africa: Veterinary Vaccines Market, by Distribution Channel, 2021–2030 (USD Million)
Table 151 Recent Developments, by Company (2020–2024)
List of Figures
Figure 1 Research Process
Figure 2 Secondary Sources Referenced for this Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Global Veterinary Vaccines Market, by Type, 2024 Vs. 2030 (USD Million)
Figure 8 Global Veterinary Vaccines Market, by Animal Type, 2024 Vs. 2030 (USD Million)
Figure 9 Global Veterinary Vaccines Market, by Administration Route, 2024 Vs. 2030 (USD Million)
Figure 10 Global Veterinary Vaccines Market, by Distribution Channel, 2024 Vs. 2030 (USD Million)
Figure 11 Global Veterinary Vaccines Market, by Geography
Figure 12 Market Dynamics: Veterinary Vaccines Market
Figure 13 Global Veterinary Vaccines Market, by Type, 2024 Vs. 2030 (USD Million)
Figure 14 Global Veterinary Vaccines Market, by Animal Type, 2024 Vs. 2030 (USD Million)
Figure 15 Global Veterinary Vaccines Market, by Administration Route, 2024 Vs. 2030 (USD Million)
Figure 16 Global Veterinary Vaccines Market, by Distribution Channel, 2024 Vs. 2030 (USD Million)
Figure 17 Global Veterinary Vaccines Market, by Geography, 2024 Vs. 2030 (USD Million)
Figure 18 North America: Veterinary Vaccines Market Snapshot
Figure 19 Europe: Veterinary Vaccines Market Snapshot
Figure 20 Asia-Pacific: Veterinary Vaccines Market Snapshot
Figure 21 Latin America: Veterinary Vaccines Market Snapshot
Figure 22 Key Growth Strategies Adopted by Leading Players (2020–2022)
Figure 23 Global Veterinary Vaccines Market: Competitive Benchmarking Based on Type
Figure 24 Global Veterinary Vaccines Market: Competitive Benchmarking Based on Geography
Figure 25 Market Share Analysis: Veterinary Vaccines Market (2022)
Figure 26 Zoetis Inc.: Financial Overview (2022)
Figure 27 Virbac: Financial Overview (2022)
Figure 28 Boehringer Ingelheim International GmbH: Financial Overview (2022)
Figure 29 Phibro Animal Health Corporation: Financial Overview (2022)
Figure 30 Merck & Co., Inc: Financial Overview (2022)
Figure 31 Elanco Animal Health Inc.: Financial Overview (2022)
Figure 32 Neogen Corporation: Financial Overview (2022)
Proudly Partnering With Enterprises Around the Globe
Quick Contact
Related Reports
Viral Vaccines Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Jun-2024
Veterinary Ultrasound Market - Global Opportunity Analysis and Industry Forecast (2024-2030)
Published Date: Jun-2024
Vaccines Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: May-2024
Veterinary API Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Mar-2024
